NovoCure

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO

Asaf Danziger

CEOAsaf Danziger

Employees

1,167

Employees1,167

Headquarters

St. Helier, Jersey

HeadquartersSt. Helier, Jersey

Founded

2000

Founded2000

Employees

1,167

Employees1,167

NVCR Key Statistics

Market cap

8.80B

Market cap8.80B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

448.85K

Average volume448.85K

High today

—

High today—

Low today

—

Low today—

Open price

$77.31

Open price$77.31

Volume

0.00

Volume0.00

52 Week high

$94.00

52 Week high$94.00

52 Week low

$56.39

52 Week low$56.39

NVCR News

Benzinga 3d

NovoCure shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight. - NovoCure - Benzinga

Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use t...

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

14.3%

Sell

28.6%

NVCR Earnings

-$0.26

-$0.17

-$0.07

$0.02

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 23, Pre-Market

ActualExpected Feb 23, Pre-Market